Oppenheimer Asset Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Oppenheimer Asset Management’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-7,923	Closed	-$453K	–	1216
2017 Q4	$453K	Hold	7,923	–	–	0.01%	809
2017 Q3	$453K	Sell	7,923 -44	-0.6%	-$2.58K	0.01%	813
2017 Q2	$480K	Buy	7,967 +257	+3%	+$14.6K	0.01%	791
2017 Q1	$419K	Buy	+7,710	New	+$380K	0.01%	833

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Oppenheimer Asset Management's BIVV Position: Q1 2018 in Review

Oppenheimer Asset Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 7,923 shares — an estimated $453K sold.

Oppenheimer Asset Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $480K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Oppenheimer Asset Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Oppenheimer Asset Management sold 7,923 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $453K.
Oppenheimer Asset Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Oppenheimer Asset Management's Bioverativ Inc. Common Stock position peaked at $480K in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Oppenheimer Asset Management's 13F filing for Q1 2018, filed 9 May 2018.